Axsome Therapeutics Australia Pty Ltd

Status: Registered
Australian Company Number: 606254095
Australian Business Number: 22606254095
Registration date: Thu, 4th Jun 2015
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Axsome Therapeutics Australia Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2015-06-04 and was issued with the 606254095 ACN. Its Australian Business Number is 22606254095. Since 2015-07-27, the company is headquartered in QLD, post code 4000. The previous headquarters were located in QLD 4000 (from 2015-07-16 to 2015-07-27). Axsome Therapeutics Australia Pty Ltd was registered for the GST on 2015-07-16. The above data comes from the ABN database which was updated on 2016-01-12.

Advertisements

Details for ABN 22606254095

Type: Australian Private Company

ABN Status

Status From To
Active Thu, 16th Jul 2015 current

Main Name

Name From To
Axsome Therapeutics Australia Pty Ltd Thu, 16th Jul 2015 current

Main Location

Location From To
QLD 4000 Mon, 27th Jul 2015 current
QLD 4000 Thu, 16th Jul 2015 Mon, 27th Jul 2015

Goods & Services Tax (GST)

Status From To
Registered Thu, 16th Jul 2015 current

Advertisements

Find company

QLD 4000 Location

2017 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2015 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2015, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.